ATE420202T1 - Nukleinsäure liganden die dna-polymerase binden und inhibieren - Google Patents
Nukleinsäure liganden die dna-polymerase binden und inhibierenInfo
- Publication number
- ATE420202T1 ATE420202T1 AT96919197T AT96919197T ATE420202T1 AT E420202 T1 ATE420202 T1 AT E420202T1 AT 96919197 T AT96919197 T AT 96919197T AT 96919197 T AT96919197 T AT 96919197T AT E420202 T1 ATE420202 T1 AT E420202T1
- Authority
- AT
- Austria
- Prior art keywords
- bind
- nucleic acid
- ligands
- dna polymerase
- acid ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/487,720 US5874557A (en) | 1990-06-11 | 1995-06-07 | Nucleic acid ligand inhibitors to DNA polymerases |
US08/484,557 US5693502A (en) | 1990-06-11 | 1995-06-07 | Nucleic acid ligand inhibitors to DNA polymerases |
US08/487,426 US5763173A (en) | 1990-06-11 | 1995-06-07 | Nucleic acid ligand inhibitors to DNA polymerases |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE420202T1 true ATE420202T1 (de) | 2009-01-15 |
Family
ID=27413687
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT09000032T ATE494394T1 (de) | 1995-06-07 | 1996-06-05 | Nukleinsäureliganden, die an dna-polymerasen binden und diese inhibieren |
AT96919197T ATE420202T1 (de) | 1995-06-07 | 1996-06-05 | Nukleinsäure liganden die dna-polymerase binden und inhibieren |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT09000032T ATE494394T1 (de) | 1995-06-07 | 1996-06-05 | Nukleinsäureliganden, die an dna-polymerasen binden und diese inhibieren |
Country Status (11)
Country | Link |
---|---|
US (1) | US6020130A (de) |
EP (2) | EP2080813B1 (de) |
JP (2) | JP4335975B2 (de) |
AT (2) | ATE494394T1 (de) |
AU (1) | AU726844B2 (de) |
CA (1) | CA2223078C (de) |
DE (2) | DE69637805D1 (de) |
DK (2) | DK0833944T3 (de) |
ES (1) | ES2321243T3 (de) |
PT (1) | PT833944E (de) |
WO (1) | WO1996041010A1 (de) |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060084797A1 (en) * | 1990-06-11 | 2006-04-20 | Gilead Sciences, Inc. | High affinity TGFbeta nucleic acid ligands and inhibitors |
US5475096A (en) * | 1990-06-11 | 1995-12-12 | University Research Corporation | Nucleic acid ligands |
US20040132067A1 (en) * | 1990-06-11 | 2004-07-08 | Somalogic, Inc. | Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
US6395888B1 (en) * | 1996-02-01 | 2002-05-28 | Gilead Sciences, Inc. | High affinity nucleic acid ligands of complement system proteins |
US6458539B1 (en) * | 1993-09-17 | 2002-10-01 | Somalogic, Inc. | Photoselection of nucleic acid ligands |
US6183967B1 (en) * | 1995-06-07 | 2001-02-06 | Nexstar Pharmaceuticals | Nucleic acid ligand inhibitors to DNA polymerases |
US7070925B1 (en) | 1996-07-16 | 2006-07-04 | Gen-Probe Incorporated | Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe |
ATE339514T1 (de) | 1996-07-16 | 2006-10-15 | Gen Probe Inc | Verfahren zum nachweis und amplifikation von nukleinsäuresequenzen unter verbrauch von modifizierten oligonukleotiden mit erhöhter zielschmelztemperatur (tm) |
US6426335B1 (en) * | 1997-10-17 | 2002-07-30 | Gilead Sciences, Inc. | Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
DE69931928T2 (de) | 1998-07-31 | 2007-01-04 | Gen-Probe Inc., San Diego | Reversibel inhibierende sonden |
EP1002875A1 (de) * | 1998-11-17 | 2000-05-24 | Mira Diagnostica GmbH | Oligonucleotid Inhibitor von thermostabilen Polymerasen |
JP2002543795A (ja) * | 1999-05-12 | 2002-12-24 | インビトロゲン・コーポレーション | 核酸合成の感度および特異性の増大のための組成物および方法 |
JP2002544496A (ja) * | 1999-05-12 | 2002-12-24 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 蛋白質プロセッティビティ因子相互作用の阻害剤をデザインするための構造ベースのアプローチ |
CA2377780A1 (en) * | 1999-07-02 | 2001-01-11 | Invitrogen Corporation | Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
US6830902B1 (en) | 1999-07-02 | 2004-12-14 | Invitrogen Corporation | Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
US6214557B1 (en) * | 2000-06-06 | 2001-04-10 | Washington University | Cold sensitive mutant DNA polymerases |
US8568766B2 (en) * | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
EP2336166A1 (de) | 2000-10-12 | 2011-06-22 | University Of Rochester | Zusammensetzungen die die Proliferation von Krebszellen hemmen |
US7300922B2 (en) | 2001-05-25 | 2007-11-27 | Duke University | Modulators of pharmacological agents |
US6667165B2 (en) | 2001-11-13 | 2003-12-23 | Eppendorf Ag | Method and compositions for reversible inhibition of thermostable polymerases |
ATE469167T1 (de) | 2002-02-06 | 2010-06-15 | Vicor Technologies Inc | Anti-infarkt-moleküle |
EP1534729A2 (de) * | 2002-02-26 | 2005-06-01 | University of Utah Research Foundation | Mit bluthochdruck und virusknospung assoziierte nedd4l-varianten |
US20040249130A1 (en) * | 2002-06-18 | 2004-12-09 | Martin Stanton | Aptamer-toxin molecules and methods for using same |
CA2487809A1 (en) * | 2002-06-18 | 2003-12-24 | Archemix Corp. | Aptamer-toxin molecules and methods for using same |
US20040110235A1 (en) * | 2002-07-25 | 2004-06-10 | David Epstein | Regulated aptamer therapeutics |
EP1575992A4 (de) | 2002-08-05 | 2007-02-21 | Univ Rochester | Chimäre proteine aus proteintransduzierender domäne/deaminase, verwandte verbindungen und deren verwendungen |
US9303262B2 (en) * | 2002-09-17 | 2016-04-05 | Archemix Llc | Methods for identifying aptamer regulators |
US8853376B2 (en) | 2002-11-21 | 2014-10-07 | Archemix Llc | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
US10100316B2 (en) * | 2002-11-21 | 2018-10-16 | Archemix Llc | Aptamers comprising CPG motifs |
US20050124565A1 (en) * | 2002-11-21 | 2005-06-09 | Diener John L. | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
AU2003294437A1 (en) * | 2002-11-21 | 2004-06-18 | Archemix Corporation | Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
WO2004050899A2 (en) * | 2002-12-03 | 2004-06-17 | Archemix Corporation | Method for in vitro selection of 2’-substituted nucleic acids |
US20050037394A1 (en) * | 2002-12-03 | 2005-02-17 | Keefe Anthony D. | Method for in vitro selection of 2'-substituted nucleic acids |
EP1615942B1 (de) | 2003-04-01 | 2016-03-16 | Luminex Corporation | Polymeraseinhibitor und verfahren zu dessen anwendung |
US20050250106A1 (en) * | 2003-04-24 | 2005-11-10 | David Epstein | Gene knock-down by intracellular expression of aptamers |
ATE418621T1 (de) * | 2003-04-24 | 2009-01-15 | Afshin Ahmadian | Verfahren zur detektion allelspezifischer mutationen |
US7727969B2 (en) * | 2003-06-06 | 2010-06-01 | Massachusetts Institute Of Technology | Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
US20050112585A1 (en) * | 2003-11-21 | 2005-05-26 | Dominic Zichi | Method for adjusting the quantification range of individual analytes in a multiplexed assay |
EP3736335A1 (de) * | 2004-02-12 | 2020-11-11 | Archemix LLC | Aptamer-therapeutika zur behandlung komplementär hervorgerufener erkrankungen |
US7803931B2 (en) | 2004-02-12 | 2010-09-28 | Archemix Corp. | Aptamer therapeutics useful in the treatment of complement-related disorders |
US20060193821A1 (en) * | 2004-03-05 | 2006-08-31 | Diener John L | Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
US20070066550A1 (en) * | 2004-03-05 | 2007-03-22 | Diener John L | Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
US20080214489A1 (en) * | 2004-04-19 | 2008-09-04 | Anthony Dominic Keefe | Aptamer-mediated intracellular delivery of oligonucleotides |
US7579450B2 (en) * | 2004-04-26 | 2009-08-25 | Archemix Corp. | Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics |
US7566701B2 (en) * | 2004-09-07 | 2009-07-28 | Archemix Corp. | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
WO2006029258A2 (en) * | 2004-09-07 | 2006-03-16 | Archemix Corp. | Aptamer medicinal chemistry |
JP2008512098A (ja) | 2004-09-07 | 2008-04-24 | アーケミックス コーポレイション | フォン・ビルブラント因子に対するアプタマー、および血栓性疾患の処置剤としてのその使用 |
US7517977B2 (en) * | 2004-10-18 | 2009-04-14 | Brandeis University | Reagents and methods for improving reproducibility and reducing mispriming in PCR amplification |
US20060228726A1 (en) * | 2005-01-06 | 2006-10-12 | Martin Patrick K | Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification |
US7829673B2 (en) | 2005-03-23 | 2010-11-09 | Genmab A/S | Antibodies against CD38 for treatment of multiple myeloma |
US7476733B2 (en) * | 2005-03-25 | 2009-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease |
US20070059713A1 (en) | 2005-09-09 | 2007-03-15 | Lee Jun E | SSB-DNA polymerase fusion proteins |
CA2624634A1 (en) * | 2005-10-03 | 2007-04-12 | Applera Corporation | Compositions, methods, and kits for amplifying nucleic acids |
AU2006302245A1 (en) * | 2005-10-06 | 2007-04-19 | Emthrax, Llc | Methods and compositions relating to anthrax spore glycoproteins as vaccines |
US8080534B2 (en) | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
EP2189522A1 (de) | 2005-10-14 | 2010-05-26 | MUSC Foundation For Research Development | PAX2 als Ziel zur Induktion einer Immunität gegen DEFB1-vermittelte Tumore und bei der Krebstherapie |
ES2364983T3 (es) * | 2006-02-27 | 2011-09-20 | F. Hoffmann-La Roche Ag | Reacción en cadena de polimerasa con arranque en caliente por secuestro de magnesio. |
HUE026496T2 (en) * | 2006-03-08 | 2016-06-28 | Archemix Llc | Complement-binding aptamers and anti-C5 agents for treating eye diseases |
RU2394915C2 (ru) * | 2006-03-24 | 2010-07-20 | Александр Борисович Четверин | Бесконтактные способы обнаружения молекулярных колоний, наборы реагентов и устройство для их осуществления |
DE102006015960A1 (de) | 2006-04-04 | 2007-10-11 | Qiagen Gmbh | Gemisch reversibel inhibierter Enzyme |
US7786294B2 (en) * | 2006-06-08 | 2010-08-31 | Saint Louis University | Compositions and methods for amplification and cloning of near full-length viral genome samples |
US8334099B2 (en) * | 2006-07-31 | 2012-12-18 | Wanli Bi | Nucleic acid amplification using a reversibly modified oligonucleotide |
US9045522B2 (en) | 2006-07-31 | 2015-06-02 | Wanli Bi | Nucleic acid amplification using a reversibly modified oligonucleotide |
EP3034083B1 (de) | 2006-09-21 | 2020-12-09 | University of Rochester | Antisense-oligonukleotide zur behandlung von myotoner dystrophie |
EP2104516B1 (de) | 2006-11-01 | 2015-01-07 | University of Rochester | Verfahren und zusammensetzungen in zusammenhang mit der struktur und funktion von apobec3g |
EP2104509A4 (de) | 2006-12-11 | 2010-03-24 | Univ Utah Res Found | Zusammensetzungen und verfahren zur behandlung von pathologischer angiogenese und gefässpermeabilität |
WO2008134077A1 (en) * | 2007-04-30 | 2008-11-06 | Archemix Corp. | Metabolic profile directed aptamer medicinal chemistry |
WO2008150495A2 (en) * | 2007-06-01 | 2008-12-11 | Archemix Corp. | Vwf aptamer formulations and methods for use |
PT2172566E (pt) * | 2007-07-17 | 2015-06-23 | Somalogic Inc | Método para gerar aptámeros com taxas de dissociação melhoradas |
DK2195331T3 (da) * | 2007-08-28 | 2014-02-03 | Uab Research Foundation | Syntetiske polypeptider, der efterligner apolipoprotein e, og anvendelsesmetoder |
CA2697957A1 (en) | 2007-08-28 | 2009-03-12 | Uab Research Foundation | Synthetic apolipoprotein e mimicking polypeptides and methods of use |
WO2010070380A2 (en) * | 2007-12-03 | 2010-06-24 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health | Doc1 compositions and methods for treating cancer |
US20090233993A1 (en) * | 2008-03-06 | 2009-09-17 | Burnham Institute For Medical Research | Compositions and methods for inhibiting gsk3 activity and uses thereof |
CA2658520C (en) | 2008-03-19 | 2016-11-08 | F. Hoffmann-La Roche Ag | Nucleic acid amplification in the presence of modified randomers |
EP2853897A1 (de) | 2008-05-08 | 2015-04-01 | University Of Utah Research Foundation | Sensorische Rezeptoren für chronische Müdigkeit und Schmerzen und Verwendungen davon |
US8816095B2 (en) * | 2008-08-15 | 2014-08-26 | Georgetown University | Na channels, disease, and related assays and compositions |
US7910720B2 (en) * | 2008-09-09 | 2011-03-22 | Roche Diagnostics Operations, Inc. | Polyanion for improved nucleic acid amplification |
US20120070443A1 (en) | 2008-12-02 | 2012-03-22 | University Of Utah Research Foundation | Pde1 as a target therapeutic in heart disease |
EP2373804B1 (de) * | 2008-12-05 | 2014-11-12 | DNA Polymerase Technology, Inc. | Zusammensetzungen für verbesserte genamplifikation |
US9034605B2 (en) | 2009-03-12 | 2015-05-19 | Brandeis University | Reagents and methods for PCR |
US20110060000A1 (en) | 2009-09-10 | 2011-03-10 | Maurizio Grimaldi | Acridine analogs in the treatment of gliomas |
US8236570B2 (en) | 2009-11-03 | 2012-08-07 | Infoscitex | Methods for identifying nucleic acid ligands |
US8841429B2 (en) * | 2009-11-03 | 2014-09-23 | Vivonics, Inc. | Nucleic acid ligands against infectious prions |
US20110207789A1 (en) | 2010-02-19 | 2011-08-25 | Ye Fang | Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents |
US20110250598A1 (en) | 2010-04-12 | 2011-10-13 | Ulrike Fischer | Detergent free polymerases |
EP2606149B1 (de) | 2010-08-20 | 2017-08-02 | Life Technologies Corporation | Polymerasetest mit fret-substrat |
EP2686007B1 (de) | 2011-03-15 | 2019-04-24 | University of Utah Research Foundation | Verfahren zur diagnose und behandlung von gefässmakulopathie und symptomen davon |
JP5977000B2 (ja) * | 2011-07-12 | 2016-08-24 | アークレイ株式会社 | 核酸の増幅検出方法およびキット |
JP5830286B2 (ja) * | 2011-07-12 | 2015-12-09 | アークレイ株式会社 | 核酸の増幅検出方法およびキット |
CA2853103C (en) | 2011-10-21 | 2020-01-07 | Decimadx, Llc | Point-of-care immunoassay for quantitative small analyte detection |
US9932634B2 (en) | 2012-05-24 | 2018-04-03 | University Of Utah Research Foundation | Methods for fast nucleic acid amplification |
CN110343673B (zh) | 2012-06-14 | 2024-04-05 | 生命技术公司 | 用于聚合酶链式反应(pcr)的新型组合物、方法和试剂盒 |
US9212392B2 (en) | 2012-09-25 | 2015-12-15 | Exact Sciences Corporation | Normalization of polymerase activity |
US10251906B2 (en) | 2013-03-12 | 2019-04-09 | University Of Utah Research Foundation | Compositions and methods for inducing apoptosis |
CN103966184A (zh) * | 2014-05-06 | 2014-08-06 | 江西省科学院微生物研究所 | 一种实时热启动Taq酶及其制备方法 |
JP7081923B2 (ja) | 2014-07-31 | 2022-06-07 | ユーエイビー リサーチ ファンデーション | アポe模倣ペプチド及び血漿コレステロールを取り除くためのより高い効果 |
ES2916153T3 (es) | 2015-11-05 | 2022-06-28 | Univ Utah Res Found | PCR extrema para transcripción inversa |
WO2017176894A1 (en) | 2016-04-06 | 2017-10-12 | Ohio State Innovation Foundation | Rna ligand-displaying exosomes for specific delivery of therapeutics to cell by rna nanotechnology |
JP7069135B2 (ja) | 2016-06-15 | 2022-05-17 | ユニヴァーシティー オブ ユタ リサーチ ファウンデーション | アルブミンベースのナノ医薬品を使用するための組成物及び方法 |
US11123435B2 (en) | 2016-08-03 | 2021-09-21 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | TLR9 targeted therapeutics |
WO2019046288A1 (en) | 2017-08-31 | 2019-03-07 | Massachusetts Institute Of Technology | MULTIPLEX COMPOSITIONS AND ASSAYS FOR CHARACTERIZING ACTIVE PROTEASE AND THEIR INHIBITORS |
WO2019051355A1 (en) | 2017-09-08 | 2019-03-14 | Ohio State Innovation Foundation | NEW MICROARN INHIBITOR THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS |
US11198722B2 (en) | 2017-10-06 | 2021-12-14 | University Of Utah Research Foundation | Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use |
CN107619430B (zh) * | 2017-10-17 | 2021-01-15 | 江西省科学院微生物研究所 | 一种热稳定的Taq酶温控亲和性配体及其制备方法、应用 |
GB201812192D0 (en) | 2018-07-26 | 2018-09-12 | Ttp Plc | Variable temperature reactor, heater and control circuit for the same |
WO2020058967A1 (en) | 2018-09-21 | 2020-03-26 | King Abdullah University Of Science And Technology | Ligand detection by aptamers with a built-in reporter |
US20230227833A1 (en) * | 2020-06-22 | 2023-07-20 | Nuhigh Biotechnologies Co., Ltd. | Nucleic acid ligand and use thereof |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS562226A (en) | 1979-06-13 | 1981-01-10 | Nissan Motor Co Ltd | Dozing drive detector |
EP0590689B2 (de) * | 1985-03-30 | 2006-08-16 | KAUFFMAN, Stuart A. | Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren |
US5354657A (en) * | 1988-01-12 | 1994-10-11 | Boehringer Mannheim Gmbh | Process for the highly specific detection of nucleic acids in solid |
WO1989006694A1 (en) * | 1988-01-15 | 1989-07-27 | Trustees Of The University Of Pennsylvania | Process for selection of proteinaceous substances which mimic growth-inducing molecules |
US5348010A (en) | 1989-02-24 | 1994-09-20 | Medrea, Inc., Pennsylvania Corp., Pa. | Intracavity probe and interface device for MRI imaging and spectroscopy |
US5580737A (en) * | 1990-06-11 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | High-affinity nucleic acid ligands that discriminate between theophylline and caffeine |
US5543293A (en) * | 1990-06-11 | 1996-08-06 | Nexstar Pharmaceuticals, Inc. | DNA ligands of thrombin |
US5503978A (en) * | 1990-06-11 | 1996-04-02 | University Research Corporation | Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
US5527894A (en) * | 1990-06-11 | 1996-06-18 | Nexstar Pharmacueticals, Inc. | Ligands of HIV-1 tat protein |
US5496938A (en) * | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
US5476766A (en) * | 1990-06-11 | 1995-12-19 | Nexstar Pharmaceuticals, Inc. | Ligands of thrombin |
US5587468A (en) * | 1990-06-11 | 1996-12-24 | University Research Corporation | High affinity nucleic acid ligands to HIV integrase |
US5567588A (en) * | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
US5637459A (en) | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
US5705337A (en) | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
US5459015A (en) * | 1990-06-11 | 1995-10-17 | Nexstar Pharmaceuticals, Inc. | High-affinity RNA ligands of basic fibroblast growth factor |
US5683867A (en) | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
US5475096A (en) | 1990-06-11 | 1995-12-12 | University Research Corporation | Nucleic acid ligands |
US5472841A (en) * | 1990-06-11 | 1995-12-05 | Nexstar Pharmaceuticals, Inc. | Methods for identifying nucleic acid ligands of human neutrophil elastase |
AU1435492A (en) * | 1991-02-21 | 1992-09-15 | Gilead Sciences, Inc. | Aptamer specific for biomolecules and method of making |
US5338671A (en) * | 1992-10-07 | 1994-08-16 | Eastman Kodak Company | DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody |
US5567604A (en) * | 1993-04-23 | 1996-10-22 | Aronex Pharmaceuticals, Inc. | Anti-viral guanosine-rich oligonucleotides |
US20170110787A1 (en) | 2015-10-14 | 2017-04-20 | Apple Inc. | Electronic Devices With Millimeter Wave Antennas And Metal Housings |
-
1996
- 1996-06-05 JP JP50176797A patent/JP4335975B2/ja not_active Expired - Lifetime
- 1996-06-05 AU AU61598/96A patent/AU726844B2/en not_active Expired
- 1996-06-05 DE DE69637805T patent/DE69637805D1/de not_active Expired - Lifetime
- 1996-06-05 EP EP09000032A patent/EP2080813B1/de not_active Expired - Lifetime
- 1996-06-05 PT PT96919197T patent/PT833944E/pt unknown
- 1996-06-05 AT AT09000032T patent/ATE494394T1/de active
- 1996-06-05 DK DK96919197T patent/DK0833944T3/da active
- 1996-06-05 US US08/945,734 patent/US6020130A/en not_active Expired - Fee Related
- 1996-06-05 DE DE69638318T patent/DE69638318D1/de not_active Expired - Lifetime
- 1996-06-05 AT AT96919197T patent/ATE420202T1/de active
- 1996-06-05 WO PCT/US1996/009451 patent/WO1996041010A1/en active Application Filing
- 1996-06-05 ES ES96919197T patent/ES2321243T3/es not_active Expired - Lifetime
- 1996-06-05 DK DK09000032.4T patent/DK2080813T3/da active
- 1996-06-05 CA CA002223078A patent/CA2223078C/en not_active Expired - Lifetime
- 1996-06-05 EP EP96919197A patent/EP0833944B1/de not_active Expired - Lifetime
-
2008
- 2008-09-10 JP JP2008263257A patent/JP2009106277A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0833944B1 (de) | 2009-01-07 |
JPH11507223A (ja) | 1999-06-29 |
EP2080813A1 (de) | 2009-07-22 |
DK2080813T3 (da) | 2011-03-28 |
PT833944E (pt) | 2009-04-14 |
JP4335975B2 (ja) | 2009-09-30 |
CA2223078A1 (en) | 1996-12-19 |
DE69637805D1 (de) | 2009-02-26 |
JP2009106277A (ja) | 2009-05-21 |
EP0833944A1 (de) | 1998-04-08 |
WO1996041010A1 (en) | 1996-12-19 |
DK0833944T3 (da) | 2009-05-11 |
ES2321243T3 (es) | 2009-06-03 |
AU726844B2 (en) | 2000-11-23 |
DE69638318D1 (de) | 2011-02-17 |
AU6159896A (en) | 1996-12-30 |
CA2223078C (en) | 2008-11-25 |
EP0833944A4 (de) | 1999-12-01 |
ATE494394T1 (de) | 2011-01-15 |
US6020130A (en) | 2000-02-01 |
EP2080813B1 (de) | 2011-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE420202T1 (de) | Nukleinsäure liganden die dna-polymerase binden und inhibieren | |
HK1044803A1 (en) | Nucleic acid ligand inhibitors to dna polymerases | |
ES2169736T3 (es) | Amplificacion de largas secuencias de acidos nucleicos mediante pcr. | |
DK0970240T3 (da) | Kunstig fejlparringshydridisering | |
DE69827060D1 (de) | Modifizierte Primer | |
DE69940662D1 (de) | Verfahren zur dna-amplifikation und -sequenzierung | |
DE60336639D1 (de) | Verfahren zur verwendung von mit fet markierten oligonucleotiden mit einer 3 -5-exonuclease-resistenten quencher-domäne und zusammensetzungen zur durchführung des verfahrens | |
ATE357529T1 (de) | Methode und zusammensetzungen zur verbesserten polynucleotidsynthese | |
WO1996006949A3 (en) | Nucleic acid hybridization assay probes targeted to mycoplasma pneumoniae nucleic acid | |
ATE476523T1 (de) | Verfahren zur genomamplifikation | |
ATE361377T1 (de) | Leistungstarke verknüpfung von nukleinsäuresegmenten | |
WO2001009347A3 (en) | Archaeal replication accessory factors and methods of use | |
DE50213026D1 (de) | Tifikation in einer probe | |
DK1543438T3 (da) | Fremgangsmåde og systemer til estimering af smelte-temperaturen (Tm) for polynukleotidmolekyler | |
ATE496122T1 (de) | Thermostabile polymerase aus i thermococcus pacificus /i | |
DE59712270D1 (de) | Verfahren zur kombination von paralleler oligonukleotidsynthese und darstellung von oligomer-chips | |
Chenchik et al. | Method for suppressing dna fragment amplification during pcr | |
Stemmer | Enzymatic inverse polymerase chain reaction | |
Rust et al. | Method of detecting variant nucleic acids | |
Schumm et al. | Allelic ladders for short tandem repeat loci | |
WO2002050094A3 (en) | Nucleic acid synthesis by primer extension on successive templates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0833944 Country of ref document: EP |